The market for HLA typing market is projected to experience substantial expansion, with an anticipated compound annual growth rate (CAGR) of 5.6% from 2022 through 2029. By the conclusion of this period, the market is expected to reach an approximate value of $1.9 billion, according to insights from Meticulous Research®. This growth reflects the increasing significance of HLA typing in various healthcare applications, especially in the field of organ transplantation.
Request For Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5311?
Critical Role of HLA Typing in Organ Transplants
HLA typing is vital for the success of organ transplantation since HLA genes, found in nearly all nucleated cells, are essential in determining whether the body accepts or rejects transplanted organs. Accurate matching of HLA markers between donor and recipient is crucial for successful transplants. As the demand for organ transplants continues to rise, the importance of HLA typing has become even more pronounced.
Growing Incidence of Organ Failure
The rising rates of organ failure can be linked to an increase in chronic health issues, including diabetes, hypertension, metabolic syndrome, and chronic kidney disease (CKD). The Centers for Disease Control and Prevention (CDC) noted that about 37 million individuals in the U.S. were diagnosed with CKD in 2021, highlighting the increasing need for organ transplants. Furthermore, improved success rates in post-transplant outcomes drive the demand for effective HLA typing solutions.
